1 Min Read
June 26 (Reuters) - THERACLION SA:
* THERACLION ANNOUNCES FDA AUTHORIZATION TO START U.S. TRIAL FOR IMMUNOTHERAPY AND ECHOTHERAPY COMBINATION ON BREAST CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.